What You Should Know:
– Tiny Health, a pioneer in at-home gut microbiome testing for babies, announced today the successful closing of an $8.5M Series A funding round.
– Led by Spero Ventures, this round brings Tiny Health’s total funding to $13M, further fueling the company’s mission to revolutionize gut health innovation and address the growing crisis of pediatric chronic conditions.
Combating a National Crisis
The United States faces a pediatric chronic conditions crisis, with over 40% of children struggling with at least one such condition, including eczema, asthma, diabetes, obesity, and food allergies. This number is steadily rising, causing immense strain on families and healthcare systems.
A Mother’s Mission, a Company’s Vision
Founded in 2020 by a mother seeking to heal her child’s gut-related health struggles, Tiny Health leverages the expertise of microbiologists, pediatric physicians, and scientists. Their state-of-the-art at-home tests provide:
– Comprehensive gut and vaginal microbiome analyses
– Actionable recommendations to optimize gut health and address imbalances
– Detection of over 120,000 microbes* using shotgun metagenomics sequencing, the most advanced technology available
Tiny Health now offers tests for adults, children (3-17), and vaginal health, addressing microbiome health across all life stages. Tiny Health conducts IRB-approved clinical studies to evaluate the effectiveness of its tests in improving health outcomes, particularly for mothers and infants.
